WORLD HEALTH ORGANIZATION
ORGANISATION MONDIALE DE LA SANTÉ
R E S O L U T I O N REGIONAL COMMITTEE FOR THE WESTERN PACIFIC COMITÉ RÉGIONAL DU PACIFIQUE OCCIDENTAL
WPR/RC62.R3 13 October 2011
ANTIMICROBIAL RESISTANCE
The Regional Committee, Recalling resolutions WPR/RC53.R5 on Antimicrobial Resistance, WHA51.17 on Emerging and other communicable diseases, WPR/RC61.R4 on the Regional Strategy to Stop Tuberculosis in the Western Pacific (2011–2015), and WHA64.17 on Malaria, which recommended effective actions to combat antimicrobial resistance; Recognizing that combating antimicrobial resistance remains an important global public health challenge that has not been fully addressed; Further recognizing that the irrational use and inadequate management of antimicrobial medicines contribute to the development of resistance; Acknowledging that multidrug-resistant microbes put patients at risk for serious and prolonged illness which can lead to increased health care costs; Mindful of the need to strengthen laboratory capacity, infection control and surveillance; Affirming that the WHO Global Strategy for Containment of Antimicrobial Resistance provides a rational context for the development of regional and national action;
WPR/RC62.R3 page 2
Noting that the WHO Director-General's Policy Package to Combat Antimicrobial Resistance can help governments pursue multisectoral strategies to combat drug resistance, 1. ENDORSES the Director-General's Policy Package to Combat Antimicrobial Resistance;
2.
URGES Member States: (1) (2) (3) to take urgent steps to address the issues and challenges of antimicrobial resistance; to use the Policy Package, as appropriate; to develop and implement comprehensive and effective national and subnational plans
for preventing and controlling antimicrobial resistance, as appropriate; 3. REQUESTS the Regional Director: (1) (2) to take urgent steps to address the issues and challenges of antimicrobial resistance; to provide technical cooperation to Member States upon request to prevent and control antimicrobial resistance and its consequences; (3) to monitor and assess the antimicrobial resistance situation across the Region and report regularly thereon.
Seventh meeting, 13 October 2011
ANTIMICROBIAL RESISTANCE The Regional Committee, Recalling resolutions WPR/RC53.R5 on Antimicrobial Resistance, WHA51.17 on Emerging and other communicable diseases, WPR/RC61.R4 on the Regional Strategy to Stop Tuberculosis in the Western Pacific (2011–2015), and WHA64.17 on Malaria, which recommended effective actions to combat antimicrobial resistance; Recognizing that combating antimicrobial resistance remains an important global public health challenge that has not been fully addressed; Further recognizing that the irrational use and inadequate management of antimicrobial medicines contribute to the development of resistance; Acknowledging that multidrug-resistant microbes put patients at risk for serious and prolonged illness which can lead to increased health care costs; Mindful of the need to strengthen laboratory capacity, infection control and surveillance; Affirming that the WHO Global Strategy for Containment of Antimicrobial Resistance provides a rational context for the development of regional and national action; WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ R E S O L U T I O N REGIONAL COMMITTEE FOR THE WESTERN PACIFIC COMITÉ RÉGIONAL DU PACIFIQUE OCCIDENTAL WPR/RC62.R3 13 October 2011 WPR/RC62.R3 page 2 Noting that the WHO Director-General's Policy Package to Combat Antimicrobial Resistance can help governments pursue multisectoral strategies to combat drug resistance, 1. ENDORSES the Director-General's Policy Package to Combat Antimicrobial Resistance; 2. URGES Member States: (1) to take urgent steps to address the issues and challenges of antimicrobial resistance; (2) to use the Policy Package, as appropriate; (3) to develop and implement comprehensive and effective national and subnational plans for preventing and controlling antimicrobial resistance, as appropriate; 3. REQUESTS the Regional Director: (1) to take urgent steps to address the issues and challenges of antimicrobial resistance; (2) to provide technical cooperation to Member States upon request to prevent and control antimicrobial resistance and its consequences; (3) to monitor and assess the antimicrobial resistance situation across the Region and report regularly thereon. Seventh meeting, 13 October 2011